BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 824050)

  • 1. Effects of high hoses of estrogen on prolactin-binding activity and growth of carcinogen-induced mammary cancers in rats.
    Kledzik GS; Bradley CJ; Marshall S; Campbell GA; Meites J
    Cancer Res; 1976 Sep; 36(9 pt.1):3265-8. PubMed ID: 824050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of estrogen and prolactin in stimulation of carcinogen-induced mammary tumor development by a high-fat diet.
    Aylsworth CF; Van Vugt DA; Sylvester PW; Meites J
    Cancer Res; 1984 Jul; 44(7):2835-40. PubMed ID: 6426788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.
    Kelly PA; Asselin J; Caron MG; Raynaud JP; Labrie F
    Cancer Res; 1977 Jan; 37(1):76-81. PubMed ID: 187338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predominant role of prolactin in stimulating the growth of 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumor.
    Manni A; Trujillo JE; Pearson OH
    Cancer Res; 1977 Apr; 37(4):1216-9. PubMed ID: 191182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin binding to 7,12-dimethylbenz(a)anthracene-induced mammary tumors and liver in diabetic rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1977 Nov; 37(11):4070-4. PubMed ID: 409490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptors in androgen-induced breast tumor regression.
    Zava DT; McGuire WL
    Cancer Res; 1977 Jun; 37(6):1608-10. PubMed ID: 192456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin binding to dissociated cells from rat mammary tumors and mammary gland.
    Smith RD; Hilf R; Senior AE
    Cancer Biochem Biophys; 1979; 3(3):117-21. PubMed ID: 121922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin binding to R3230AC mammary carcinoma and liver in hormone-treated and diabetic rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1977 Feb; 37(2):595-8. PubMed ID: 188551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen-prolactin dependency in 7,12-dimethylbenz(a)anthracene-induced tumors.
    Leung BS; Sasaki GH; Leung JS
    Cancer Res; 1975 Mar; 35(3):621-7. PubMed ID: 163687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
    Klinge CM; Bambara RA; Zain S; Hilf R
    Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oophorectomy on estrogen receptors in rat mammary tumors induced by 7,12-dimethylbenz (a)anthracene.
    Tominaga T; Kitamura M; Tei N
    Biken J; 1977 Dec; 20(3-4):143-5. PubMed ID: 96813
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of pharmacological doses of estrogen on ovary-independent rat mammary carcinoma containing estrogen and progesterone receptors.
    Yoshida H; Fukuhara T; Yamashi S; Yoshida A; Fukunishi R; Tsuji M; Matsumoto K
    Cancer Res; 1983 May; 43(5):2311-6. PubMed ID: 6403234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and prolactin receptor concentrations in rat mammary tumors and response to endocrine ablation.
    DeSombre ER; Kledzik G; Marshall S; Meites J
    Cancer Res; 1976 Feb; 36(2 Pt 1):354-8. PubMed ID: 177195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ovariectomy and retinyl acetate on the growth of established 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat.
    Gandilhon P; Melancon R; Djiane J; Kelly PA
    J Natl Cancer Inst; 1982 Aug; 69(2):447-51. PubMed ID: 6287078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between insulin and estrogen binding to growth response in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Shafie SM; Hilf R
    Cancer Res; 1978 Mar; 38(3):759-64. PubMed ID: 414834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen effects mediated by estrogen receptor in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Garcia M; Rochefort H
    Cancer Res; 1978 Nov; 38(11 Pt 1):3922-9. PubMed ID: 100211
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship of hormones to inhibition of mammary tumor development by underfeeding during the "critical period" after carcinogen administration.
    Sylvester PW; Aylsworth CF; Meites J
    Cancer Res; 1981 Apr; 41(4):1384-8. PubMed ID: 6783295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats.
    Sylvester PW; Aylsworth CF; Van Vugt DA; Meites J
    Cancer Res; 1983 Nov; 43(11):5342-6. PubMed ID: 6413057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin receptors and androgen-induced regression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma.
    Costlow ME; Buschow RA; McGuire WL
    Cancer Res; 1976 Sep; 36(9 pt.1):3324-9. PubMed ID: 184948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.